My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 110

    1.

    Posttransplantation diabetes: a systematic review of the literature.

    Montori VM, Basu A, Erwin PJ, Velosa JA, Gabriel SE, Kudva YC.

    Diabetes Care. 2002 Mar;25(3):583-92. Review.PMID: 11874952 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.

    Woodroffe R, Yao GL, Meads C, Bayliss S, Ready A, Raftery J, Taylor RS.

    Health Technol Assess. 2005 May;9(21):1-179, iii-iv. Review.PMID: 15899149 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data.

    Webster AC, Woodroffe RC, Taylor RS, Chapman JR, Craig JC.

    BMJ. 2005 Oct 8;331(7520):810. Epub 2005 Sep 12. Review.PMID: 16157605 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients.

    Webster A, Woodroffe RC, Taylor RS, Chapman JR, Craig JC.

    Cochrane Database Syst Rev. 2005 Oct 19;(4):CD003961. Review.PMID: 16235347 [PubMed - indexed for MEDLINE]Related articles

    5.

    Cyclosporin versus tacrolimus for liver transplanted patients.

    Haddad EM, McAlister VC, Renouf E, Malthaner R, Kjaer MS, Gluud LL.

    Cochrane Database Syst Rev. 2006 Oct 18;(4):CD005161. Review.PMID: 17054241 [PubMed - indexed for MEDLINE]Related articles

    6.

    Natural history and epidemiology of post transplantation diabetes mellitus.

    Alebiosu OC, Ayodele OE.

    Afr Health Sci. 2005 Sep;5(3):255-60. Review.PMID: 16245997 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients.

    Webster AC, Lee VW, Chapman JR, Craig JC.

    Cochrane Database Syst Rev. 2006 Apr 19;(2):CD004290. Review.PMID: 16625599 [PubMed - indexed for MEDLINE]Related articles

    8.

    New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis.

    Heisel O, Heisel R, Balshaw R, Keown P.

    Am J Transplant. 2004 Apr;4(4):583-95. Review.PMID: 15023151 [PubMed - indexed for MEDLINE]Related articles

    9.

    Cyclosporine for induction of remission in Crohn's disease.

    McDonald JW, Feagan BG, Jewell D, Brynskov J, Stange EF, Macdonald JK.

    Cochrane Database Syst Rev. 2005 Apr 18;(2):CD000297. Review.PMID: 15846602 [PubMed - indexed for MEDLINE]Related articles

    10.

    Posttransplant diabetes mellitus in kidney allograft recipients: incidence, risk factors, and management.

    First MR, Gerber DA, Hariharan S, Kaufman DB, Shapiro R.

    Transplantation. 2002 Feb 15;73(3):379-86.PMID: 11884934 [PubMed - indexed for MEDLINE]Related articles

    11.

    Posttransplantation diabetes mellitus in heart transplant recipients.

    Ladowski JS, Kormos RL, Uretsky BF, Lee A, Curran M, Clark R, Armitage JM, Griffith BP, Hardesty RL.

    J Heart Transplant. 1989 Mar-Apr;8(2):181-3.PMID: 2651624 [PubMed - indexed for MEDLINE]Related articles

    12.

    Challenges in the diagnosis and management of new-onset diabetes after transplantation.

    Salifu MO, Tedla F, Murty PV, Aytug S, McFarlane SI.

    Curr Diab Rep. 2005 Jun;5(3):194-9. Review.PMID: 15929866 [PubMed - indexed for MEDLINE]Related articles

    13.

    Higher initial tacrolimus blood levels and concentration-dose ratios in kidney transplant recipients who develop diabetes mellitus.

    Rodrigo E, de Cos MA, Fernández-Fresnedo G, Sánchez B, Ruiz JC, Piñera C, Palomar R, Cotorruelo JG, Gómez-Alamillo C, de Castro SS, de Francisco AL, Arias M.

    Transplant Proc. 2005 Nov;37(9):3819-20.PMID: 16386549 [PubMed - indexed for MEDLINE]Related articles

    14.

    Clinicoepidemiologic study of posttransplant diabetes after living-donor renal transplant.

    Elmagd MM, Bakr MA, Metwally AH, Wahab AM.

    Exp Clin Transplant. 2008 Mar;6(1):42-7.PMID: 18405244 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    The first report from the patient outcomes registry for transplant effects on life (PORTEL): differences in side-effects and quality of life by organ type, time since transplant and immunosuppressive regimens.

    Hathaway D, Winsett R, Prendergast M, Subaiya I.

    Clin Transplant. 2003 Jun;17(3):183-94.PMID: 12780666 [PubMed - indexed for MEDLINE]Related articles

    16.

    High incidence of tacrolimus-associated posttransplantation diabetes in the Korean renal allograft recipients according to American Diabetes Association criteria.

    Cho YM, Park KS, Jung HS, Jeon HJ, Ahn C, Ha J, Kim SJ, Rhee BD, Kim SY, Lee HK.

    Diabetes Care. 2003 Apr;26(4):1123-8.PMID: 12663584 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Natural history, prognosis, and management of transplantation-induced diabetes mellitus.

    Benhamou PY, Penfornis A.

    Diabetes Metab. 2002 Jun;28(3):166-75. Review.PMID: 12149596 [PubMed - indexed for MEDLINE]Related articles

    18.

    Factors influencing the onset of diabetes mellitus after kidney transplantation: a single French center experience.

    Marin M, Renoult E, Bondor CI, Kessler M.

    Transplant Proc. 2005 May;37(4):1851-6.PMID: 15919484 [PubMed - indexed for MEDLINE]Related articles

    19.

    A systematic review and economic model of the clinical and cost-effectiveness of immunosuppressive therapy for renal transplantation in children.

    Yao G, Albon E, Adi Y, Milford D, Bayliss S, Ready A, Raftery J, Taylor RS.

    Health Technol Assess. 2006 Dec;10(49):iii-iv, ix-xi, 1-157. Review.PMID: 17134597 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    De novo immunosuppression with sirolimus and tacrolimus in heart transplant recipients compared with cyclosporine and mycophenolate mofetil: a one-year follow-up analysis.

    Zucker MJ, Baran DA, Arroyo LH, Goldstein DJ, Neacy C, Mele L, Weinberg AD, Prendergast TW, Ribner HS.

    Transplant Proc. 2005 Jun;37(5):2231-9.PMID: 15964386 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity